Trial Profile
A study evaluating efficacy and safety of radiation therapy in advanced melanoma patients treated with Ipilimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2017
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2017 New trial record